Search Results - Merz, Karl-Heinz
- Showing 1 - 4 results of 4
-
1
Methylisoindigo and Its bromo-derivatives are selective tyrosine kinase inhibitors, repressing cellular Stat3 activity, and target CD133+ cancer stem cells in PDAC by Tegethoff, Jana F. (Author) , Bischoff, Roland (Author) , Saleh, Sawsan (Author) , Blagojević, Biljana (Author) , Merz, Karl-Heinz (Author) , Cheng, Xinlai (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
2
Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs by Cheng, Xinlai (Author) , Kim, Jee Young (Author) , Ghafoory, Shahrouz (Author) , Duvaci, Tijen (Author) , Rafiee, Roya (Author) , Theobald, Jannick (Author) , Alborzinia, Hamed (Author) , Holenya, Pavlo (Author) , Fredebohm, Johannes (Author) , Merz, Karl-Heinz (Author) , Mehrabi, Arianeb (Author) , Hafezi, Mohammadreza (Author) , Saffari, Arash (Author) , Eisenbrand, Gerhard (Author) , Hoheisel, Jörg D. (Author) , Wölfl, Stefan (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
3
The role of indirubins in inflammation and associated tumorigenesis by Cheng, Xinlai (Author) , Merz, Karl-Heinz (Author) ,
Call Number: Loading…
Located: Loading…
Chapter/Article Online Resource -
4
Biological effects of acrylamide after daily ingestion of various foods in comparison to water: a study in rats by Berger, Franz (Author) , Feld, Julia (Author) , Bertow, Daniel (Author) , Eisenbrand, Gerhard (Author) , Fricker, Gert (Author) , Gerhardt, Natalie (Author) , Merz, Karl-Heinz (Author) , Richling, Elke (Author) , Baum, Matthias (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource
Search Tools:
Related Subjects
Indirubin
AMPK activation
AhR
CD133
CSC drug
Cancer
Inflammation
LKB1 inactivation
Meisoindigo
NF-κB
PDAC
Pancreatic cancer stem cell
STAT3
Stat3 inhibitor
Structure-activity relationship
TCM
TGF-ß
cancer stem cells
indirubin
meisoindigo
selective protein kinase inhibitor
structure-activity-relationship